Other languages NexImmune, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:30:00 26/04/2024 BST			5-day change	1st Jan Change
3.37 ^USD	-1.17%		-3.44%	+51.80%

04-17	North American Morning Briefing : Stock Futures -2-	DJ
04-16	NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-16
NexImmune, Inc. Announces Executive Changes	04-05
Top Premarket Decliners	01-04
Top Premarket Decliners	12-04
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech	12-01
Top Premarket Gainers	12-01
Investors Look Ahead to Powell Speech as US Futures Trend Lower Friday	12-01
NexImmune, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-17
Top Premarket Decliners	11-06
Top Premarket Decliners	11-03
NexImmune Extends Partnership With Yale, JDRF for Type 1 Diabetes	24/10/23
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes	24/10/23
Sector Update: Health Care Stocks Softer Late Afternoon	18/10/23
Sector Update: Health Care Stocks Sliding Wednesday Afternoon	18/10/23
NexImmune Implements 1-for-25 Reverse Stock Split	18/10/23
NexImmune Cutting Over Half of Workforce to Fund Development of Novel Therapeutic Candidates	31/08/23
NexImmune, Inc. Announces Executive Changes, Effective as of September 2, 2023	31/08/23
NexImmune, Inc. Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy	31/08/23
NexImmune, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Neximmune Announces Initial Positive Data from the NEXI-001 Phase 1 Trial for Relapsed/Refractory Post Allo-Hsct Aml At the American Society of Clinical Oncology 2023 Annual Meeting	05/06/23

No results for this search